Internal Medicine · Caro, MI
NPI
1780639450
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
11
Medicare group memberships
Hospitals
6
Hospital affiliations
1525 W Caro Rd
Caro, MI, 48723
Phone (989) 672-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$910K
15,137 services
Medicare patients, 2024
1,584
Average age 72
Drug cost, 2024
$3.9M
66,286 prescriptions
Company payments, 2025
$2,007
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naveed Mahfooz was code 99214 (office e&m - established), 2,305 times for 661 patients. In total Naveed Mahfooz billed 15,137 services in 137 codes, and Medicare paid $910K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,305 | 661 | $80.19 | $185K |
| 99308 SNF E&M | Facility | 1,233 | 198 | $53.23 | $66K |
| 99489 Chronic, Principal, and Transitional Care Management | Facility | 1,014 | 94 | $37.97 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 916 | 148 | $89.88 | $82K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 912 | 88 | $54.38 | $50K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 466 | 466 | $121.47 | $57K |
| 99309 SNF E&M | Facility | 441 | 152 | $80.00 | $35K |
| 99487 Chronic, Principal, and Transitional Care Management | Facility | 373 | 127 | $68.42 | $26K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 353 | 152 | $100.80 | $36K |
| 99442 Telephone Services | Office | 336 | 169 | $55.39 | $19K |
| 99349 Home E&M - New and Established | Office | 328 | 96 | $86.57 | $28K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 326 | 325 | $17.14 | $5,589 |
| 96372 Injection Administration | Office | 308 | 118 | $9.69 | $2,984 |
| 99497 Care Management/Coordination | Office | 307 | 307 | $74.31 | $23K |
| 99213 Office E&M - Established | Office | 307 | 206 | $58.65 | $18K |
By year: 2022 $1.1M for 18,261 services; 2023 $933K for 16,017 services; 2024 $910K for 15,137 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 75 | 60 | $2.15 | $161 |
| 36415 Venipuncture Blood Collection | 52 | 44 | $8.48 | $441 |
| 83036 Blood Count | 19 | 13 | $9.52 | $181 |
| 87880 Immunoassay | 11 | 11 | $16.20 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Naveed Mahfooz prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,856 prescriptions and refills. In total Naveed Mahfooz wrote 66,286 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,856 | 4,640 | 343 | $27K |
| Levothyroxine Sodium Generic | 3,406 | 4,185 | 272 | $22K |
| Furosemide Generic | 2,319 | 2,991 | 303 | $11K |
| Eliquis Apixaban | 1,643 | 1,816 | 153 | $518K |
| Potassium Chloride Generic | 1,611 | 1,879 | 152 | $22K |
| Amlodipine Besylate Generic | 1,609 | 2,224 | 210 | $9,116 |
| Omeprazole Generic | 1,586 | 2,197 | 203 | $14K |
| Pantoprazole Sodium Generic | 1,504 | 1,755 | 150 | $21K |
| Tamsulosin Hcl Generic | 1,466 | 1,857 | 167 | $14K |
| Metoprolol Tartrate Generic | 1,415 | 1,834 | 166 | $7,639 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,335 | 1,339 | 230 | $17K |
| Lisinopril Generic | 1,227 | 1,679 | 153 | $6,902 |
| Famotidine Generic | 1,206 | 1,276 | 71 | $9,032 |
| Gabapentin Generic | 1,204 | 1,315 | 176 | $12K |
| Metformin Hcl Generic | 1,193 | 1,569 | 130 | $5,550 |
Brand drugs: 8,305 claims; generic drugs: 57,580 claims; opioid claims: 2,155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naveed Mahfooz $2,007 ($2,007 in general payments such as food, travel and fees) from 27 companies. The largest payer was Amgen Inc. with $312.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 17 | $312 |
| Merck Sharp & Dohme LLC MRK | 11 | $220 |
| Vanda Pharmaceuticals Inc. VNDA | 9 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 12 | $164 |
| Lundbeck LLC | 7 | $158 |
| Xeris Pharmaceuticals, Inc. | 7 | $142 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $125 |
| Lilly USA, LLC LLY | 8 | $119 |
| Scpharmaceuticals Inc. SCPH | 4 | $66.06 |
| UCB, Inc. UCB.BR | 3 | $64.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.